KALEIDO BIOSCIENCES INC (KLDO)
US4833471000 - Common Stock
| 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | 2017 (2017-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 38.47M | 46.22M | 71.24M | 76.09M | 28.46M | |||
| Receivables | N/A | N/A | N/A | 10.00K | 50.00K | |||
| Other Current Assets | 3.84M | 2.50M | 2.04M | 150.00K | 50.00K | |||
| Total Current Assets | 42.31M | 48.72M | 73.28M | 76.24M | 28.55M | |||
| Non-Current Assets | ||||||||
| PPE Net | 5.67M | 8.46M | 6.74M | 4.69M | 1.98M | |||
| Other Non-Current Assets | 2.16M | 2.16M | 2.29M | 4.39M | 220.00K | |||
| Total Non-Current Assets | 7.83M | 10.62M | 9.03M | 9.09M | 2.20M | |||
| TOTAL ASSETS | 50.14M | 59.34M | 82.31M | 85.33M | 30.75M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 16.14M | 2.63M | 70.00K | 90.00K | 100.00K | |||
| Accrued Expenses | 6.69M | 7.36M | 7.09M | 7.41M | 2.62M | |||
| Accounts Payable | 5.67M | 5.39M | 2.02M | 3.44M | 860.00K | |||
| Other Current Liabilities | 1.18M | 1.28M | 1.21M | 360.00K | 270.00K | |||
| Total Current Liabilities | 29.68M | 16.66M | 10.38M | 11.30M | 3.85M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 5.55M | 18.38M | 20.39M | 14.83M | 14.81M | |||
| Other Non-Current Liabilities | 4.30M | 3.81M | 2.66M | 2.21M | 3.27M | |||
| Total Non-Current Liabilities | 9.85M | 22.19M | 23.04M | 17.04M | 18.08M | |||
| TOTAL LIABILITIES | 39.53M | 38.85M | 33.42M | 28.34M | 21.93M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -364.47M | -274.18M | -192.56M | -106.23M | -44.48M | |||
| Additional Paid In Capital | 375.03M | 294.64M | 241.41M | 9.98M | 800.00K | |||
| Common Shares | 43.00K | 40.00K | 30.00K | 153.24M | 52.50M | |||
| Shares Outstanding | 42.60M | 36.02M | 30.13M | 29.39M | 29.39M | |||
| Tangible Book Value per Share | 0.25 | 0.57 | 1.62 | -3.27 | -1.49 | |||
| Total Shareholders' Equity | 10.61M | 20.50M | 48.88M | 56.98M | 8.82M | |||
| TOTAL LIABILITIES AND EQUITY | 50.14M | 59.34M | 82.31M | 85.33M | 30.75M | |||
| Statistics | ||||||||
| Debt/Equity | 0.52 | 0.90 | 0.42 | 0.26 | 1.68 | |||
| Current Ratio | 1.43 | 2.92 | 7.06 | 6.75 | 7.42 | |||
| Return On Assets (ROA) | -180.08% | -137.55% | -104.88% | -72.35% | -89.63% | |||
| Return On Equity (ROE) | -851.21% | -398.15% | -176.62% | -108.35% | -312.47% | |||
All data in USD